News
The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...
Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard ...
Onsite in Chicago at ASCO 2025, web editor Nicole Raleigh sat down with Dr Danny Nguyen, medical oncologist and haematologist ...
The Association of the British Pharmaceutical Industry (ABPI) has said that the new 10-year plan for the NHS has underplayed ...
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
A European pharma trade organisation has said that a new strategy launched by the EU to bolster the region's standing in life ...
President Donald Trump has signed an executive order aimed at lowering drug prices for Americans that includes a plan to do away with what the industry claims is a major flaw in the Biden era ...
Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs. First ...
The targeted radiopharmaceutical field is undergoing significant expansion, with progressing clinical candidates and growing novel pipelines. Precision radiopharmaceuticals repres ...
In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare diseases, the unique challenges faced by pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results